86 related articles for article (PubMed ID: 16532491)
21. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
22. Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.
Karha J; Gurm HS; Rajagopal V; Fathi R; Bavry AA; Brener SJ; Lincoff AM; Ellis SG; Bhatt DL
Am J Cardiol; 2006 Oct; 98(7):906-10. PubMed ID: 16996871
[TBL] [Abstract][Full Text] [Related]
23. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry).
Minutello RM; Chou ET; Hong MK; Bergman G; Parikh M; Iacovone F; Wong SC
Am J Cardiol; 2004 May; 93(10):1229-32. PubMed ID: 15135694
[TBL] [Abstract][Full Text] [Related]
24. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
[TBL] [Abstract][Full Text] [Related]
25. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
[TBL] [Abstract][Full Text] [Related]
26. Temporal trends in target vessel revascularization in clinical practice: long-term outcomes following coronary stenting from the Duke Database for Cardiovascular Disease.
Kandzari DE; Tuttle RH; Zidar JP; Jollis JG
J Invasive Cardiol; 2006 Sep; 18(9):398-402. PubMed ID: 16954575
[TBL] [Abstract][Full Text] [Related]
27. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
[TBL] [Abstract][Full Text] [Related]
28. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.
Diercks DB; Roe MT; Mulgund J; Pollack CV; Kirk JD; Gibler WB; Ohman EM; Smith SC; Boden WE; Peterson ED
Am Heart J; 2006 Jul; 152(1):140-8. PubMed ID: 16824844
[TBL] [Abstract][Full Text] [Related]
29. The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.
White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Steinhubl S; Montalescot G
Am Heart J; 2009 Jan; 157(1):125-31. PubMed ID: 19081408
[TBL] [Abstract][Full Text] [Related]
30. Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II).
Khattab AA; Daemen J; Richardt G; Rioux P; Amann FW; Levy R; Horvath IG; Teles RC; Ordoubadi F; Pieters M; Wittebols K; Stoll HP; Serruys PW
Am J Cardiol; 2008 Jun; 101(11):1550-9. PubMed ID: 18489932
[TBL] [Abstract][Full Text] [Related]
31. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.
Nair S; Verma S; Thuluvath PJ
Hepatology; 2002 Jan; 35(1):105-9. PubMed ID: 11786965
[TBL] [Abstract][Full Text] [Related]
32. Thiazolidinediones do not reduce target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention.
Cho L; Lewis BE; Steen LH; Leya FS
Cardiology; 2005; 104(2):97-100. PubMed ID: 16020949
[TBL] [Abstract][Full Text] [Related]
33. Impact of body mass index on outcomes of enhanced external counterpulsation therapy.
McCullough PA; Silver MA; Kennard ED; Kelsey SF; Michaels AD;
Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368306
[TBL] [Abstract][Full Text] [Related]
34. Sex difference in the effect of obesity on prognosis for patients undergoing percutaneous coronary intervention.
Wang ZJ; Zhao YX; Liu YY; Shi DM; Gao F; Liu XL; Yu M; Zhou YJ
Coron Artery Dis; 2012 Sep; 23(6):404-11. PubMed ID: 22828723
[TBL] [Abstract][Full Text] [Related]
35. Obesity and long-term clinical and economic outcomes in coronary artery disease patients.
Eisenstein EL; Shaw LK; Nelson CL; Anstrom KJ; Hakim Z; Mark DB
Obes Res; 2002 Feb; 10(2):83-91. PubMed ID: 11836453
[TBL] [Abstract][Full Text] [Related]
36. Obesity and clinical restenosis after coronary stent placement.
Rana JS; Mittleman MA; Ho KK; Cutlip DE
Am Heart J; 2005 Oct; 150(4):821-6. PubMed ID: 16209988
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous renal cryoablation in obese and morbidly obese patients.
Schmit GD; Thompson RH; Boorjian SA; McDonald RJ; Kurup AN; Weisbrod AJ; Kor DJ; Callstrom MR; Atwell TD
Urology; 2013 Sep; 82(3):636-41. PubMed ID: 23890665
[TBL] [Abstract][Full Text] [Related]
38. Effect of body mass index on Argatroban therapy during percutaneous coronary intervention.
Hursting MJ; Jang IK
J Thromb Thrombolysis; 2008 Jun; 25(3):273-9. PubMed ID: 17530465
[TBL] [Abstract][Full Text] [Related]
39. Obese patients with abdominal pain presenting to the emergency department do not require more time or resources for evaluation than nonobese patients.
Platts-Mills TF; Burg MD; Snowden B
Acad Emerg Med; 2005 Aug; 12(8):778-81. PubMed ID: 16079433
[TBL] [Abstract][Full Text] [Related]
40. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes.
Zahr F; Genovese E; Mathier M; Shullo M; Lockard K; Zomak R; McNamara D; Toyoda Y; Kormos RL; Teuteberg JJ
Ann Thorac Surg; 2011 Oct; 92(4):1420-6. PubMed ID: 21958791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
